ReviewBritish journal of clinical pharmacology2013

How biologics targeting the IL-1 system are being considered for the treatment of type 2 diabetes.

Marianne Böni-Schnetzler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.